Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat covid-19

The present invention provides pharmaceutical compositions and methods of treating Covid-19 infectious disease. The present invention also provides pharmaceutical compositions and methods of prophylaxis or prophylactic treatment of Covid-19 infectious disease. The said methods involve administering...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: PATEL, Manit, MERCHANT, Shreema, DUNCAN, Robin Elaine, JADHAV, Vishal Anant, FERNANDES, Maria Fernanda de Andrade
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator PATEL, Manit
MERCHANT, Shreema
DUNCAN, Robin Elaine
JADHAV, Vishal Anant
FERNANDES, Maria Fernanda de Andrade
description The present invention provides pharmaceutical compositions and methods of treating Covid-19 infectious disease. The present invention also provides pharmaceutical compositions and methods of prophylaxis or prophylactic treatment of Covid-19 infectious disease. The said methods involve administering compositions comprising therapeutically effective amount of Cannabidiol thereby causing enhancement / augmentation of innate immunity of the patient / mammal/human due to at least one of the following effects, i) infected patient cells undergo apoptosis early after infection; ii) induction of interferon transcription in the patient; iii) induction of interferon-induced antiviral effectors in the patient.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2021313476A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2021313476A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2021313476A13</originalsourceid><addsrcrecordid>eNqNjMEKwjAQRHvxIOo_LHgOmFYUj6UoerXqtYR0SwNptmRXBb_etvgBnobhvZl58rkEwWisOApADZT5tVQFPVQKfSRBFxjeTlroyKN9ehPBhBosej-VDm1rguOOx3VLLBPjyWoodoM1fjMIgUQ0A6eXq5U-LJNZYzzj6peLZH063oqzwp4q5N5YDChVfk83qc50tt3vcp39Z30BrLRGmw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat covid-19</title><source>esp@cenet</source><creator>PATEL, Manit ; MERCHANT, Shreema ; DUNCAN, Robin Elaine ; JADHAV, Vishal Anant ; FERNANDES, Maria Fernanda de Andrade</creator><creatorcontrib>PATEL, Manit ; MERCHANT, Shreema ; DUNCAN, Robin Elaine ; JADHAV, Vishal Anant ; FERNANDES, Maria Fernanda de Andrade</creatorcontrib><description>The present invention provides pharmaceutical compositions and methods of treating Covid-19 infectious disease. The present invention also provides pharmaceutical compositions and methods of prophylaxis or prophylactic treatment of Covid-19 infectious disease. The said methods involve administering compositions comprising therapeutically effective amount of Cannabidiol thereby causing enhancement / augmentation of innate immunity of the patient / mammal/human due to at least one of the following effects, i) infected patient cells undergo apoptosis early after infection; ii) induction of interferon transcription in the patient; iii) induction of interferon-induced antiviral effectors in the patient.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230316&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021313476A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230316&amp;DB=EPODOC&amp;CC=AU&amp;NR=2021313476A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>PATEL, Manit</creatorcontrib><creatorcontrib>MERCHANT, Shreema</creatorcontrib><creatorcontrib>DUNCAN, Robin Elaine</creatorcontrib><creatorcontrib>JADHAV, Vishal Anant</creatorcontrib><creatorcontrib>FERNANDES, Maria Fernanda de Andrade</creatorcontrib><title>Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat covid-19</title><description>The present invention provides pharmaceutical compositions and methods of treating Covid-19 infectious disease. The present invention also provides pharmaceutical compositions and methods of prophylaxis or prophylactic treatment of Covid-19 infectious disease. The said methods involve administering compositions comprising therapeutically effective amount of Cannabidiol thereby causing enhancement / augmentation of innate immunity of the patient / mammal/human due to at least one of the following effects, i) infected patient cells undergo apoptosis early after infection; ii) induction of interferon transcription in the patient; iii) induction of interferon-induced antiviral effectors in the patient.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjMEKwjAQRHvxIOo_LHgOmFYUj6UoerXqtYR0SwNptmRXBb_etvgBnobhvZl58rkEwWisOApADZT5tVQFPVQKfSRBFxjeTlroyKN9ehPBhBosej-VDm1rguOOx3VLLBPjyWoodoM1fjMIgUQ0A6eXq5U-LJNZYzzj6peLZH063oqzwp4q5N5YDChVfk83qc50tt3vcp39Z30BrLRGmw</recordid><startdate>20230316</startdate><enddate>20230316</enddate><creator>PATEL, Manit</creator><creator>MERCHANT, Shreema</creator><creator>DUNCAN, Robin Elaine</creator><creator>JADHAV, Vishal Anant</creator><creator>FERNANDES, Maria Fernanda de Andrade</creator><scope>EVB</scope></search><sort><creationdate>20230316</creationdate><title>Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat covid-19</title><author>PATEL, Manit ; MERCHANT, Shreema ; DUNCAN, Robin Elaine ; JADHAV, Vishal Anant ; FERNANDES, Maria Fernanda de Andrade</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2021313476A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>PATEL, Manit</creatorcontrib><creatorcontrib>MERCHANT, Shreema</creatorcontrib><creatorcontrib>DUNCAN, Robin Elaine</creatorcontrib><creatorcontrib>JADHAV, Vishal Anant</creatorcontrib><creatorcontrib>FERNANDES, Maria Fernanda de Andrade</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>PATEL, Manit</au><au>MERCHANT, Shreema</au><au>DUNCAN, Robin Elaine</au><au>JADHAV, Vishal Anant</au><au>FERNANDES, Maria Fernanda de Andrade</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat covid-19</title><date>2023-03-16</date><risdate>2023</risdate><abstract>The present invention provides pharmaceutical compositions and methods of treating Covid-19 infectious disease. The present invention also provides pharmaceutical compositions and methods of prophylaxis or prophylactic treatment of Covid-19 infectious disease. The said methods involve administering compositions comprising therapeutically effective amount of Cannabidiol thereby causing enhancement / augmentation of innate immunity of the patient / mammal/human due to at least one of the following effects, i) infected patient cells undergo apoptosis early after infection; ii) induction of interferon transcription in the patient; iii) induction of interferon-induced antiviral effectors in the patient.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2021313476A1
source esp@cenet
subjects CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Interaction of SARS-CoV-2 proteins with molecular and cellular mechanisms of host cells and formulations to treat covid-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T22%3A56%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=PATEL,%20Manit&rft.date=2023-03-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2021313476A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true